Understand the Association Between Peritoneal Dialysis Status and Gene Polymorphisms of VEGF and KDR
NCT04888065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-05-17
Summary
Peritoneal dialysis (PD) is an effective and successful way of renal replacement therapy. The initial transport status is related to distribution of blood vessels and micro inflammation state in peritoneum before PD. Vascular endothelial growth factor(VEGF) and its receptor, kinase insert domain containing receptor(KDR) may play important roles on initial transport status.
This study include 200 PD patients from Renji Hospital in Shanghai, China. According to the 4h D/P Cr within three months of starting PD therapy, we analyzed the association between the polymorphisms of VEGF and KDR and initial peritoneal transport property.
Conditions
- Peritoneal Dialysis
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Principal Investigators
-
YUE QIAN, MD · RenJi Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-10
- Primary Completion
- 2020-10-30
- Completion
- 2020-12-30
Countries
- China
Study Locations
More Related Trials
-
Improving Outcomes in Peritoneal Dialysis
NCT02207751 ·Status: WITHDRAWN
-
The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease
NCT06841224 ·Status: ENROLLING_BY_INVITATION
-
The Effect of Exercise on Blood Pressure Variability on Peritoneal Dialysis Patients
NCT07098923 ·Status: COMPLETED ·Phase: NA
-
A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform
NCT03571451 ·Status: RECRUITING
-
Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry
NCT05841082 ·Status: UNKNOWN
-
Biological Determinants of Peritoneal Dialysis
NCT02694068 ·Status: COMPLETED
-
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
NCT06597201 ·Status: RECRUITING ·Phase: PHASE4
-
Relationship of Peritoneal Solute Transport Rate With VEGF in Children Undergoing Peritoneal Dialysis
NCT00516061 ·Status: UNKNOWN
-
Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD)
NCT00931970 ·Status: UNKNOWN
-
Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate
NCT01779557 ·Status: COMPLETED ·Phase: PHASE4
-
Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
NCT00291863 ·Status: UNKNOWN ·Phase: PHASE4
-
Potential Biomarkers of the Severity of Endothelial Damage in End-stage Chronic Kidney Failure
NCT02857556 ·Status: TERMINATED ·Phase: NA
-
Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
NCT00420290 ·Status: COMPLETED ·Phase: NA
-
Cross-control Study on the Effect of Peritoneal Rest on Peritoneal Transport Function in Peritoneal Dialysis Patients
NCT05805813 ·Status: COMPLETED ·Phase: NA
-
Independent Effects of Visceral Adipose Volume and Density on Patient Survival in Peritoneal Dialysis
NCT07086430 ·Status: COMPLETED
-
Vascular Access Choice and Outcomes in the Elderly and Very Elderly With End Stage Renal Disease in China
NCT02272374 ·Status: UNKNOWN ·Phase: NA
-
Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula
NCT06199609 ·Status: COMPLETED
-
The Study of Efficacy and Safety of Automated PD in Urgent Start Dialysis
NCT03754361 ·Status: TERMINATED ·Phase: NA
-
The Benefit of Hemodialysis Plus Hemoperfusion on Mortality
NCT03227770 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD
NCT01637792 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China
NCT02378350 ·Status: COMPLETED ·Phase: PHASE4
-
Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2
NCT02212327 ·Status: COMPLETED
-
Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients
NCT01575652 ·Status: COMPLETED ·Phase: PHASE4
-
Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
NCT00516880 ·Status: UNKNOWN ·Phase: NA
-
Characteristics and Clinical Outcomes of Peritoneal Dialysis Patients
NCT05224466 ·Status: UNKNOWN